Expression of the von Hippel-Lindau gene protein in breast cancer tissue [2]

Gynecologic Oncology

Volumn 84, Issue 1, 2002, Pages 186-187

  Lantzsch, Tilmann ^a   Hefler, Lukas ^a   Koelbl, Heinz ^a   Lampe, Dieter ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GENE PRODUCT; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

AUTOSOMAL DOMINANT DISORDER; BREAST CANCER; CELL CYCLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEMANGIOBLASTOMA; HEMANGIOMATOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LETTER; MAJOR CLINICAL STUDY; PATHOLOGICAL ANATOMY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; VON HIPPEL LINDAU DISEASE;

EID: 0036142825     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6419     Document Type: Editorial

References (7)

1. Clustering of features of von Hippel-Lindau syndrome: Evidence for a complex genetic locus
2. Von Hippel-Lindau disease: Clinical and molecular perspectives
3. Recombinant adenovirus expressing Von Hippel-Lindau-mediated cell cycle arrest is associated with the induction of cyclin-dependent kinase inhibitor p27Kipl
4. Von Hippel-Lindau tumor suppressor gene is not involved in sporadic human breast cancer
5. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas
6. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
7. Expression of von Hippel-Lindau protein in normal and pathological human tissues